☰

Heather A. Boger - Publications

Affiliations: 
MUSC, Santa Clara, Villa Clara, Cuba 
Area:
dopamine, GDNF, Parkinson's disease
Tree Info Grants Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Farrand A, Verner R, McGuire R, Helke K, Hinson V, Boger H. Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease. Brain Stimulation. PMID 32629028 DOI: 10.1016/j.brs.2020.06.078  0.324
2020 Zhang Y, Song L, Dong H, Kim DS, Sun Z, Boger H, Wang Q, Wang H. Spinophilin-deficient Mice are Protected from Diet-induced Obesity and Insulin Resistance. American Journal of Physiology. Endocrinology and Metabolism. PMID 32603260 DOI: 10.1152/ajpendo.00114.2020  0.333
2020 Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D, Chandran R, Shields DC, Farrand AQ, Boger HA, Banik NL. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Experimental Neurology. 113315. PMID 32302678 DOI: 10.1016/J.Expneurol.2020.113315  0.36
2019 Hamlett ED, Ledreux A, Gilmore A, Vazey EM, Aston-Jones G, Boger HA, Paredes D, Granholm AE. Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome. Neurobiology of Disease. 134: 104616. PMID 31678403 DOI: 10.1016/J.Nbd.2019.104616  0.755
2019 Farrand AQ, Helke KL, Aponte-Cofresí L, Gooz MB, Gregory RA, Hinson VK, Boger HA. Effects of vagus nerve stimulation are mediated in part by TrkB in a Parkinson's disease model. Behavioural Brain Research. 112080. PMID 31301412 DOI: 10.1016/j.bbr.2019.112080  0.389
2018 Hascup ER, Broderick SO, Russell MK, Fang Y, Bartke A, Boger HA, Hascup KN. Diet-Induced Insulin Resistance Elevates Hippocampal Glutamate as well as VGLUT1 and GFAP Expression in AβPP/PS1 Mice. Journal of Neurochemistry. PMID 30472734 DOI: 10.1111/Jnc.14634  0.434
2017 Scholpa NE, Lynn MK, Corum D, Boger HA, Schnellmann RG. 5-HT1F Receptor-Mediated Mitochondrial Biogenesis for the Treatment of Parkinson's Disease. British Journal of Pharmacology. PMID 29057453 DOI: 10.1111/bph.14076  0.367
2017 Farrand AQ, Helke KL, Gregory RA, Gooz M, Hinson VK, Boger HA. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease. Brain Stimulation. PMID 28918943 DOI: 10.1016/j.brs.2017.08.008  0.36
2016 Hamlett ED, Goetzl EJ, Ledreux A, Vasilevko V, Boger HA, LaRosa A, Clark D, Carroll SL, Carmona Iragui M, Fortea J, Mufson EJ, Sabbagh M, Mohammed AH, Hartley D, Doran E, et al. Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27755974 DOI: 10.1016/j.jalz.2016.08.012  0.66
2016 Farrand AQ, Gregory RA, Bäckman CM, Helke KL, Boger HA. Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease. Brain Research. PMID 27659966 DOI: 10.1016/j.brainres.2016.09.025  0.668
2016 Becker-Krail D, Farrand AQ, Boger HA, Lavin A. Effects of fingolimod administration in a genetic model of cognitive deficits. Journal of Neuroscience Research. PMID 27439747 DOI: 10.1002/Jnr.23799  0.335
2016 Hascup KN, Lynn MK, Fitzgerald PJ, Randall S, Kopchick JJ, Boger HA, Bartke A, Hascup ER. Enhanced Cognition and Hypoglutamatergic Signaling in a Growth Hormone Receptor Knockout Mouse Model of Successful Aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 27208894 DOI: 10.1093/Gerona/Glw088  0.445
2016 Rosenberger DS, Falangola MF, Ledreux A, Nie X, Suhre WM, Boger HA, Granholm AC. MEMORY AND HIPPOCAMPAL ARCHITECTURE FOLLOWING SHORT-TERM MIDAZOLAM IN WESTERN DIET-TREATED RATS. Neuroscience Letters. PMID 27080429 DOI: 10.1016/j.neulet.2016.04.021  0.685
2015 Spratt EG, Granholm AC, Carpenter LA, Boger HA, Papa CE, Logan S, Chaudhary H, Boatwright SW, Brady KT. Pilot Study and Review: Physiological Differences in BDNF, a Potential Biomarker in Males and Females with Autistic Disorder. International Neuropsychiatric Disease Journal. 3: 19-26. PMID 26866045 DOI: 10.9734/INDJ/2015/12118  0.669
2015 Ledreux A, Boger HA, Hinson VK, Cantwell K, Granholm AC. BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson׳s disease. Brain Research. PMID 26607251 DOI: 10.1016/j.brainres.2015.11.028  0.673
2015 Hamlett E, Boger HA, Ledreux A, Kelley CM, Mufson EJ, Falangola MF, Guilfoyle DN, Nixon RA, Patterson D, Duval N, Granholm AE. Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome. Current Alzheimer Research. PMID 26391050 DOI: 10.2174/1567205012666150921095505  0.706
2015 Fortress AM, Hamlett ED, Vazey EM, Aston-Jones G, Cass WA, Boger HA, Granholm AC. Designer receptors enhance memory in a mouse model of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 1343-53. PMID 25632113 DOI: 10.1523/Jneurosci.2658-14.2015  0.803
2015 Farrand AQ, Gregory RA, Scofield MD, Helke KL, Boger HA. Effects of aging on glutamate neurotransmission in the substantia nigra of Gdnf heterozygous mice. Neurobiology of Aging. 36: 1569-76. PMID 25577412 DOI: 10.1016/J.Neurobiolaging.2014.11.017  0.466
2015 Nie X, Hamlett ED, Granholm AC, Hui ES, Helpern JA, Jensen JH, Boger HA, Collins HR, Falangola MF. Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: a diffusional kurtosis imaging study. Magnetic Resonance Imaging. 33: 437-47. PMID 25527393 DOI: 10.1016/J.Mri.2014.12.008  0.754
2014 Cunningham MA, Wirth JR, Freeman LR, Boger HA, Granholm AC, Gilkeson GS. Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. Journal of Neuroinflammation. 11: 171. PMID 25510908 DOI: 10.1186/S12974-014-0171-X  0.797
2014 Reinert KR, Umphlet CD, Quattlebaum A, Boger HA. Short-term effects of an endotoxin on substantia nigra dopamine neurons. Brain Research. 1557: 164-70. PMID 24513404 DOI: 10.1016/j.brainres.2014.02.005  0.405
2014 Karakostas T, Hsiang S, Boger H, Middaugh L, Granholm AC. Three-dimensional rodent motion analysis and neurodegenerative disorders. Journal of Neuroscience Methods. 231: 31-7. PMID 24129039 DOI: 10.1016/J.Jneumeth.2013.09.009  0.639
2013 Littrell OM, Granholm AC, Gerhardt GA, Boger HA. Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF. Pharmacology, Biochemistry, and Behavior. 104: 10-9. PMID 23290934 DOI: 10.1016/J.Pbb.2012.12.022  0.771
2012 Littrell OM, Pomerleau F, Huettl P, Surgener S, McGinty JF, Middaugh LD, Granholm AC, Gerhardt GA, Boger HA. Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiology of Aging. 33: 427.e1-14. PMID 21144620 DOI: 10.1016/J.Neurobiolaging.2010.10.013  0.762
2012 Alanis M, Umphlet C, Boger H, Granholm A. 426: Adolescent cognitive and anxiety behavior in offspring following in utero exposure to increased trans unsaturated fatty acids through maternal diet American Journal of Obstetrics and Gynecology. 206: S197. DOI: 10.1016/J.AJOG.2011.10.444  0.625
2011 Lockrow J, Boger H, Gerhardt G, Aston-Jones G, Bachman D, Granholm AC. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model. Journal of Alzheimer's Disease : Jad. 23: 471-89. PMID 21098982 DOI: 10.3233/JAD-2010-101218  0.806
2011 Granholm AC, Zaman V, Godbee J, Smith M, Ramadan R, Umphlet C, Randall P, Bhat NR, Rohrer B, Middaugh LD, Boger HA. Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathology (Zurich, Switzerland). 21: 330-48. PMID 20969653 DOI: 10.1111/J.1750-3639.2010.00457.X  0.756
2011 Boger HA, Mannangatti P, Samuvel DJ, Saylor AJ, Bender TS, McGinty JF, Fortress AM, Zaman V, Huang P, Middaugh LD, Randall PK, Jayanthi LD, Rohrer B, Helke KL, Granholm AC, et al. Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. Genes, Brain, and Behavior. 10: 186-98. PMID 20860702 DOI: 10.1111/J.1601-183X.2010.00654.X  0.806
2011 Lockrow J, Boger H, Bimonte-Nelson H, Granholm AC. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behavioural Brain Research. 221: 610-22. PMID 20363261 DOI: 10.1016/j.bbr.2010.03.036  0.778
2010 Boger HA, Granholm AC, McGinty JF, Middaugh LD. A dual-hit animal model for age-related parkinsonism. Progress in Neurobiology. 90: 217-29. PMID 19853012 DOI: 10.1016/J.Pneurobio.2009.10.013  0.739
2009 Boger HA, Middaugh LD, Granholm AC, McGinty JF. Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiology of Disease. 33: 459-66. PMID 19110059 DOI: 10.1016/J.Nbd.2008.11.013  0.755
2008 Granholm AC, Boger H, Emborg ME. Mood, memory and movement: an age-related neurodegenerative complex? Current Aging Science. 1: 133-9. PMID 20021382 DOI: 10.2174/1874609810801020133  0.682
2008 Zaman V, Boger HA, Granholm AC, Rohrer B, Moore A, Buhusi M, Gerhardt GA, Hoffer BJ, Middaugh LD. The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior. The European Journal of Neuroscience. 28: 1557-68. PMID 18973577 DOI: 10.1111/J.1460-9568.2008.06456.X  0.795
2008 Boger HA, Middaugh LD, Zaman V, Hoffer B, Granholm AC. Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Research. 1241: 18-28. PMID 18822276 DOI: 10.1016/J.Brainres.2008.09.011  0.762
2007 Boger HA, Middaugh LD, Patrick KS, Ramamoorthy S, Denehy ED, Zhu H, Pacchioni AM, Granholm AC, McGinty JF. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8816-25. PMID 17699663 DOI: 10.1523/Jneurosci.1067-07.2007  0.77
2007 af Bjerkén S, Boger HA, Nelson M, Hoffer BJ, Granholm AC, Strömberg I. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Research. 1133: 10-9. PMID 17184739 DOI: 10.1016/j.brainres.2006.11.052  0.719
2006 Boger HA, Middaugh LD, Huang P, Zaman V, Smith AC, Hoffer BJ, Tomac AC, Granholm AC. A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Experimental Neurology. 202: 336-47. PMID 16889771 DOI: 10.1016/J.Expneurol.2006.06.006  0.798
2006 Griffin WC, Boger HA, Granholm AC, Middaugh LD. Partial deletion of glial cell line-derived neurotrophic factor (GDNF) in mice: Effects on sucrose reward and striatal GDNF concentrations. Brain Research. 1068: 257-60. PMID 16364262 DOI: 10.1016/J.Brainres.2005.10.080  0.739
2006 Hascup KN, Broderick SO, Russell MK, Boger HA, Hascup ER. P2-160: DIETARY INSULIN RESISTANCE IMPAIRS COGNITION AND ELEVATES HIPPOCAMPAL GLUTAMATE DYNAMICS IN AβPP/PS1 MICE Alzheimer's & Dementia. 14: P729-P730. DOI: 10.1016/J.Jalz.2018.06.847  0.346
2004 Quintero EM, Willis LM, Zaman V, Lee J, Boger HA, Tomac A, Hoffer BJ, Strömberg I, Granholm AC. Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway. Neuroscience. 124: 137-46. PMID 14960346 DOI: 10.1016/j.neuroscience.2003.11.001  0.762
Show low-probability matches.